baber/WOPTO huggingface dataset:
Patent NZ-551199-A (NZ)
Title: Methods of reducing nematode damage
Inventor: ANGST MAX
IPC: A01N37/44
Filed: 2005-06-06
Abstract: Disclosed is a method of reducing damage to a plant or plant propagation material or plant organs which grow during the life of a plant, by a representative of the class of Nematoda, which method comprises (i) treating the plant or plant propagation material with (A) a chelating agent before the plant or the material is sown or planted, or (ii) applying (A) a chelating agent to the locus of the plant, the material or the treated material defined in (i) before its planting, and/or at its planting and/or during its growth, wherein the chelating agent is polycarboxylic acid and provided, when the chelating agent is metallated, the metal is selected from Cr, Mn, Fe, Co, Ni, Cu and Zn.
Patent NZ-553126-A (NZ)
Title: Compositions and methods for angiogenesis related molecules and treatments
Inventor: KREMMIDIOTIS GABRIEL
IPC: C12N15/113
Filed: 2005-08-09
Abstract: Provided is a short interfering RNA (siRNA) molecule with a specified sequence comprising a complement of a segment of an mRNA transcribed from the GTPase activating protein rhoGAP (BNO69), wherein said siRNA molecule modulates the expression of BN069 by RNA interference. The composition can be used to treat angiogenesis-related disorders.
Patent NZ-553830-A (NZ)
Title: Interconnect assembly for a clam style portable communication device
Inventor: GARCIA JORGE L
IPC: H04M1/00
Filed: 2005-08-31
Abstract: A portable communication device is disclosed. The portable communication device comprises a flip compartment which is electrically coupled to a main radio compartment via an external flex through a hinge. The external flex seals both the flip compartment and main radio compartments independently of each other via a first seal and a second seal.
Patent NZ-562399-A (NZ)
Title: Method for synchronizing exporter and exciter clocks
Inventor: KROEGER BRIAN WILLIAM
IPC: H04H1/00
Filed: 2006-02-14
Abstract: A method for synchronizing an exciter clock with a modem frame clock in an IBOC broadcasting system is disclosed. The method comprises the steps of receiving a plurality of modem frame pulses that are representative of the start of modem frames of audio signals and data signals, wherein timing of the modem frame pulses is controlled by a modem frame clock, producing an exciter clock signal, counting pulses representative of the exciter clock signal to produce a count representative of timing error of each incoming modem frame pulse, and controlling the exciter clock signal in response to the count. An apparatus that performs the method is also provided.
Patent NZ-563222-A (NZ)
Title: Analysing breath samples for volatile organic compound
Inventor: SCOTTER JENNIFER M
IPC: C12Q1/04
Filed: 2006-04-13
Abstract: Provided is a method of using pentylfuran as a biomarker to detect microorganisms, expecially fungal pathogens and Aspergillus sp. in gaseous biosamples from breath of an animal, including human, or from an air sample from a microbial culture.
Patent NZ-566518-A (NZ)
Title: Yeast volatile thiol production in mixed ferments
Inventor: GODDARD MATTHEW ROBERT
IPC: C12N1/16
Filed: 2008-03-07
Abstract: Provided is an isolated Pichia kluyveri yeast strain as deposited at the National Measurement Institute under accession number V06/022711 or V06/022712. The strain can be combined with a Saccharomyces cerevisiae strain for a fermentation resulting in a synergistic increase in thiol production. The product may be an alcoholic beverage.
Patent NZ-572303-A (NZ)
Title: Paper forming fabric and/or tissue molding belt and/or molding belt with predetermined permeabiility range and other parameters
Inventor: LIPPI ALVES FERNANDES ADEMAR
IPC: D21F11/00
Filed: 2007-04-27
Abstract: A forming fabric for what is described as an ATMOS system or a TAD machine is disclosed. The forming fabric includes a permeability value of between approximately 100 cfm and approximately 1200 cfm, a paper surface contact area of between approximately 0.5% and approximately 90% when not under pressure and tension, and an open area of between approximately 1.0% and approximately 90%. A belt press for a paper machine can utilize the forming fabric.
Patent NZ-577719-A (NZ)
Title: Pyrazol-1-yl-aryl amides and their analogues and their pharmaceutical uses
Inventor: KLING ANDREAS
IPC: A61K31/4155
Filed: 2007-12-28
Abstract: Disclosed are pyrazol-1-yl-aryl carboxamides and their derivatives as represented by the general formula (I), wherein Y is a divalent, aromatic or 6-membered heteroaromatic radical which has 1 or 2 nitrogen atoms as ring members and which optionally has 1 or 2 substituents Ry: W is a radical of the formula W1 or else it forms together with R2 a tricyclic radical of the formula W6, which is linked via nitrogen; and wherein the remaining substituents are as defined herein. Representative compounds include N-{ 1-[amino(oxo)acetyl]pentyl} -5-chloro-2-(3-phenyl-1H-pyrazol-1-yl)nicotinamide, N-(3-amino-1 -benzyl-2,3-dioxopropyl)-2-[3-(4-chorophenyI)-1H-pyrazol-1-yI]nicotinamide, N-(3-amino-1-benzyl-2,3-dioxopropyl)-2-(4,5-dihydro-2H-benzo[g]indazol-2-yI)nicotinamide, N-[3-amino-2,3-dioxo-1-(phenylmethyl)propyl]-2-(8-chlorochromeno[4,3-c]pyrazol-2(4H)-yI)pyridine-3-carboxamide, N-[3-amino-2,3-dioxo-1-(phenylmethyl)propyl]-2-(4,5-dihydro-2H-[1]benzoxepino[5,4-c]pyrazol-2-yI)pyridine-3-carboxamide and N-[3-amino-2,3-dioxo-1-(phenylmethyl)propyl]-2-[4-(dimethylamino)-3-(4-fluorophenyl)-1H-pyrazol-1-yl]pyridine-3-carboxamide. Further disclosed is a medicament which comprises at least one compound, a tautomer, a prodrug or a pharmaceutically suitable salt thereof as defined above for the treatment of a disorder, an impairment or a condition which is selected from HIV, neurodegenerative disorders, epilepsy, pain, damage to the heart following cardiac ischemias, damage to the kidneys following renal ischemias, skeletal muscle damage, muscular dystrophies, damage resulting from proliferation of smooth muscle cells, coronary vasospasms, cerebral vasospasms, macular degeneration, cataracts of the eyes, restenosis of the blood vessels following angioplasty, and a disorder or an impairment associated with an elevated interleukin-I, TNF or Ab level.
Patent NZ-579270-A (NZ)
Title: New process for the resolution of enantiomers of 1-cyano-4,5-dimethoxy-benzocyclobutane and application in the synthesis of ivabradine
Inventor: LERESTIF JEAN-MICHEL
IPC: C07C209/48
Filed: 2009-08-26
Abstract: Disclosed is a process for the optical resolution of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7yl)nitrile of formula (I) (which is also known as 1-(cyano)-4,5-(dimethoxy)-benzocyclobutane), wherein a racemic or enantiomerically enriched mixture of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile is separated into its R and S enantiomers of formula (Ia) and formula (Ib) by chiral chromatography. Also disclosed is a process for the preparation of ivabradine of formula (II) which utilises the intermediate compound of formula (Ia).
Patent NZ-585282-A (NZ)
Title: Near full-genome assay of hepatitis c virus drug resistance
Inventor: VUAGNIAUX GREGOIRE
IPC: C12N7/00
Filed: 2008-10-31
Abstract: Assays for identifying and characterising mutations in the genome of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs. The assays comprise three separate reverse transcription and PCR reactions for different areas of the viral genome.
Patent NZ-586760-A (NZ)
Title: Process for the preparation of 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid
Inventor: RALL WERNER
IPC: C07D209/34
Filed: 2009-01-22
Abstract: Disclosed is a process for the preparation of 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid (as represented by formula (I)), said process comprising the steps of (i) reacting 4-[(dimethylamino)methyl]-aniline with a compound of formula (II) or its acetyl protected derivative, and (ii) de-esterification of the propanoic acid, ethyl ester group; in which the reaction defined in step (i) is performed in the presence of a mixture of reagents and solvents selected from: a) hexamethyldisilazane and p-toluenesulfonic acid monohydrate in the presence of triethylamine; b) hexamethyldisilazane and p-toluenesulfonic acid monohydrate in the presence of pyridine; c) hexamethyldisilazane and benzenesulfonic acid in the presence of triethylamine; d) hexamethyldisilazane and benzenesulfonic acid in the presence of pyridine; e) hexamethyldisilazane and trimethylsilylchloride; f) N,O-bis(trimethylsily)acetamide and pyridine; or g) trimethylsilylimidazolide and pyridine.
Patent NZ-588819-A (NZ)
Title: 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives as inhibitors of Bruton's Tyrosine Kinase (Btk)
Inventor: DEWDNEY NOLAN JAMES
IPC: C07D401/14
Filed: 2009-06-15
Abstract: Discloses herein are 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic formulae (III) & (IV), wherein variables R, X, Y1, Y2, Y2', Y3, Y4, n and m are as defined in the specification. These compounds inhibit Bruton's Tyrosine Kinase (Btk) and are useful for the treatment of diseases caused by aberrant B-cell activation. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions comprising compounds of formulae (III) & (IV) and at least one carrier, diluent or excipient.
Patent NZ-589757-A (NZ)
Title: Clamp with grooved arms suitable for gripping a biological sample holder
Inventor: PHILIPPON MICHEL
IPC: G01N35/00
Filed: 2009-06-05
Abstract: A machine for the treatment and/or analysis of biological samples, comprises a first storage location for storing at least a first biological sample holder 10, comprising a wall provided with two opposite lateral edges, and biological sample receptacles supported by the wall, the wall extending vertically with the vertical lateral edges and the receptacles opening upwardly, and a hinged arm to which a clamp for gripping the first biological sample holder is fixed. The clamp comprises first and second arms able move relative to each other along a gripping direction Z between a first position of gripping the first biological sample holder, and a first position of releasing the biological sample holder, where the first arm 76 of the clamp comprises a first groove, the second arm 78 of the clamp comprises a second groove. When the first and second arms are in the first position of release ? the first and second grooves are spaced away from each other along the gripping direction, and when the first and second arms are in the first gripping position, the first and second grooves are brought closer to each other along the gripping direction and extend opposite each other, so as to be able to receive lateral edges of the first biological sample holder 10, and grip it by squeezing the lateral edges along the gripping direction Z.
Patent NZ-589912-A (NZ)
Title: Slump retaining admixture for modifying clay activity in concrete
Inventor: ZHANG SHU-QIANG
IPC: C04B20/02
Filed: 2009-07-10
Abstract: 589912 Disclosed is a method for modifying clay-activity and slump retention of a hydratable cementitious composition containing a clay-containing aggregate, comprising: combining with a clay-containing aggregate, in which the clay is operative to absorb or otherwise decrease dosage efficiency of a polycarboxylate dispersant, at least one cationic compound and at least one poly-hydroxyl or hydroxyl carboxylic acid or salt thereof.
Patent NZ-590123-A (NZ)
Title: Insecticidal phenyl- or pyridyl-piperidine compounds
Inventor: PITTERNA THOMAS
IPC: A01N43/40
Filed: 2009-07-06
Abstract: Disclosed is substituted piperadine compound of formula (I) where the substituents are as disclosed in the specification. Examples of compound of formula (I) include: 2-chloro-N-{ 4,5-difluoro-2-[1-(4'-fluorobiphenyl-4-ylmethyl)-piperidin-4-yl]-phenyl} -isonicotinamide; 2-chloro-N-{ 4,5-difluoro-2-[1-(4'-fluorobiphenyl-4-ylmethyl)-1-oxy-piperidin-4-yl]-phenyl} -isonicotinamide and 2-chloro-N-[6-chloro-1'-(4'-fluorobiphenyl-4-ylmethyl)-5-methyl-1',2',3',4' ,5',6'-hexahydro-[2,4']bipyridinyl-3-yl]-isonicotinamide. Also disclosed is a method for controlling insects and an insecticidal, acaricidal, nematicidal or molluscicidal composition comprising a compound of formula (I).
Patent NZ-592858-A (NZ)
Title: Fast three-phase reclosing method in shunt reactor compensated transmission lines
Inventor: VALERO PATRICIA MESTAS
IPC: H01H7/16
Filed: 2009-10-09
Abstract: 592858 Disclosed is a method for adaptive three-phase fast reclosing applied to shunt compensated transmission lines. A relay is calibrated to a factory setting default reclosing time adjusted to a high value, and the reclosing time is automatically reset to the high value after line opening. The voltage across the contacts of the switching device is measured via potential transformers and an envelope of the voltage across the circuit breaker contacts is measured. The envelope signal is then filtered to eliminate high harmonics. A circuit breaker opening instant, a first half-cycle of the filtered signal and a half-cycle semi-period of the filtered signal are then all identified. A beat period is determined after dead time and the circuit breaker reclosing time is adjusted, setting it equal to the beat period after dead time.
Patent NZ-595378-A (NZ)
Title: Immunology treatment for biofilms
Inventor: DASHPER STUART GEOFFREY
IPC: A61K38/00
Filed: 2008-07-11
Abstract: Disclosed is a composition for use in raising an immune response to P. gingivalis in a subject, the composition comprising an amount effective to raise an immune response of at least one antigenic or immunogenic portion of a polypeptide corresponding to accession number AAQ67118.1 (SEQ ID NO: 2), wherein the portion is not the full length polypeptide and comprises at least 10 contiguous amino acid residues substantially identical to 10 contiguous amino acid residues of said polypeptide. Also disclosed is the use of at least one antigenic or immunogenic portion of a polypeptide in the preparation of a medicament for preventing, inhibiting or treating periodontal disease in a subject, wherein the polypeptide corresponds to accession number AAQ67118.1 (SEQ ID NO: 2).
Patent NZ-595879-A (NZ)
Title: 1-[3-(arylamino)-pyrido[2,3-b]pyrazin-6-yl]-3-alkyl-urea derivatives and pharmaceutical uses thereof
Inventor: SEIPELT IRENE
IPC: A61K31/4375
Filed: 2006-11-10
Abstract: Abstract - 595879 Disclosed are 1-[3-(arylamino)-pyrido[2,3-b]pyrazin-6-yl]-3-alkyl-urea derivatives as represented by the general formula (I), wherein R1 is NR7R8; R7 is selected from hydrogen or alkyl; R8 independently is selected from aryl or heteroaryl and wherein the aryl- or heteroaryl substituents for their part are optionally substituted; R2 is hydrogen; R3 and R4 are independently of one another selected from hydrogen or NR9R10, assuming that if R3 = NR9R10, R4 = H, and if R4 = NR9R10, R3 = H; R9 is selected from hydrogen, alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkyl-cycloalkyl, alkyl-heterocyclyl, alkyl-aryl or alkyl-heteroaryl and the alkyl-, cycloalkyl-, heterocyclyl-, aryl- and heteroaryl-, alkyl-cycloalkyl, alkylheterocyclyl, alkyl-aryl or alkyl-heteroaryl substituents for their part are optionally substituted; R10 is selected from: C(Y)NR11R12 (wherein Y = O or S), C(Y)NR13R14 (wherein Y = NH) or R10 is selected from C(NR15)R16; and wherein the other substituents are as defined herein. Representative compounds include 1-ethyl-3-(3-p-tolylamino-pyrido[2,3-b]pyrazin-6-yl)-urea, 1-ethyl-3-[3-(4-methoxy-phenylamino)-pyrido[2,3-b]pyrazin-6-yl]-urea, 1-ethyl-3-[3-(5-methyl-pyridin-2-ylamino)-pyrido[2,3-b]pyrazin-6-yl]-urea, 1-ethyl-3-[3-(1-methyl-1H-pyrazol-3-ylamino)-pyrido[2,3-b]pyrazin-6-yl]-urea, 1-ethyl-3-[3-(quinolin-3-ylamino)-pyrido[2,3-b]pyrazin-6-yl]-urea, 1-[3-(benzothiazol-6-ylamino)-pyrido[2,3-b]pyrazin-6-yl]-3-ethyl-urea, 1-[3-(4-chloro-2-methoxy-5-methylphenylamino)-pyrido[2,3-b]pyrazin-6-yl]-3-ethyl-urea, 2-chloro-4-[6-(3-ethyl-ureido)-pyrido[2,3-b]pyrazin-3-ylamino]-benzoic acid, 1-ethyl-3-[3-(1H-indol-6-ylamino)-pyrido[2,3-b]pyrazin-6-yl]-urea and 1-ethyl-3-[3-(3-oxo-3,4-dihydro-2Hbenzo[1,4]oxazin-7-ylamino)-pyrido[2,3- b]pyrazin-6-yl]-urea. Further disclosed is a pharmaceutical composition comprising a pharmacologically active quantity of at least one compound as defined above, for use in the treatment of conditions such as inflammation, HIV infections, rheumatism, arthritis, dementia, Alzheimer's disease, hyperproliferative diseases, cancer, obesity, diabetes, metabolic diseases, solid/fixed tumours, allergies, allergic diseases, atherosclerosis, cardiovascular diseases, angiogenetic diseases, ischemia, cardiac hypertrophia etc..
Patent NZ-597471-A (NZ)
Title: Composite panel of aluminium outer layers and core with insulation with panel bent in different directions
Inventor: AL-TIAY WALID
IPC: E04C2/292
Filed: 2012-03-14
Abstract: A prefabricated structural insulation panel is made of routed, grooved flat composite panel consisting of a core bonded between sheets of aluminium, copper, stainless steel or zinc.
Patent NZ-597668-A (NZ)
Title: Novel gpr 119 agonists
Inventor: PINGALI HARIKISHORE
IPC: C07D411/12
Filed: 2010-06-17
Abstract: 597668 Disclosed herein are GPR 119 agonists of the general Formula (I) wherein the variables are defined in the specification, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, stereoisomers, and polymorphs. Additionally disclosed are processes for the preparation of the compounds, pharmaceutical compositions containing the compounds and to methods for treating one or both of diabetes and obesity using the compounds of the invention. The disclosed compounds are G-protein coupled receptor (GPCR) agonists that are useful for the treatment of obesity, diabetes and related metabolic disorders. Examples of the compounds include cis-5-(4-((6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane-2-oxide and trans-tert-butyl-4-((5-methyl-6-(4-(2-oxido-1,3,2-dioxathian-5-yl)phenoxy)pyrimidin-4-yl)oxy)piperidine-1-carboxylate.
Patent NZ-602031-A (NZ)
Title: Orthopedic foot support
Inventor: WENS HEIDI JEANNE VICTOR
IPC: A61F5/058
Filed: 2011-03-21
Abstract: 602031 Disclosed is an orthopaedic foot support to support long-term bedridden patients. It comprises of a preformed support of two parts. The first part is the top piece (2) that consists of a stiff cushion (3) with an erect wall (4) and transverse supports (5, 6, 7) connected to provide lateral support of the lower legs. The second part is the bottom piece which consists of a base (8) on which the lower legs can rest. The base (8) has a pair of cambers (10) to support the lower legs. The base (8) can be exchanged for a base with different cambers (10) suitable for another leg dimension. The top piece (2) can be removed to gain access to the legs of the patient who remains lying on the base (8), without having to move this base (8) or the legs.
Patent NZ-602175-A (NZ)
Title: Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
Inventor: PARR RYAN
IPC: C07H21/00
Filed: 2009-03-27
Abstract: 602175 Disclosed is an isolated mitochondrial fusion transcript associated with cancer, wherein the transcript comprises a nucleic acid sequence as set forth in SEQ ID NO: 19. SEQ ID NO: 19 augccccucauuuacauaaauauuauacuagcauuuaccaucucacuucuaggaauacuaguauaucgcucacaccucauauccucccuacuaugccuagaaggaauaauacuaucgcuguucauuauagcuacucucauaacccucaacacccacucccucuuagccaauauugugccuauugccauacuagucuuugccgccugcgaagcagcggugggccuagcccuacuagucucaaucuccaacacauauggccuagacuacguacauaaccuaacccuacuccuaaucacauaa
Patent NZ-607292-A (NZ)
Title: Window and door frame assemblies with snap on architraves
Inventor: HALL CHRIS
IPC: E06B1/36
Filed: 2011-08-18
Abstract: A window frame assembly for a window having side jamb sections, a head jamb and a sill section, the assembly including adjacent at least one the side jamb sections at least one stiffening assembly. Each stiffening assembly comprises a stiffening strut 12,13 having a first end 16, 22 which engages a first anchor and a second end 17,20 which engages a second anchor. The first and second anchors engage horizontal structural elements of a building to which the window frame assembly is attached. One horizontal structural element is disposed near the head jamb section of the window and another horizontal structural element is disposed near the sill section of the window.
Patent NZ-613132-A (NZ)
Title: Sports training apparatus
Inventor: ROBB PETER MITCHELL
IPC: A63B69/00
Filed: 2012-07-11
Abstract: Disclosed is a sports training apparatus for practising batting in cricket. The apparatus comprises a frame comprising at least two front spaced legs and at least one rear spaced leg arranged as a tripod or pyramid; a flexible net attached to the frame and extending across the space formed between each of the front spaced legs and the at least one rear spaced leg to form two converging net panels; and a ball suspended on a line, the line attached to the frame at a line attachment point substantially equally spaced between the front spaced legs. The two converging net panels are reinforced along each edge of the two net panels and vertically along a vertical plane where the two net panels converge from a top edge of the net to a bottom edge of the net to facilitate rebound of the ball when driven into the net. The line attachment point comprises a swivel configured to facilitate rotation of the line about the line attachment point. The converging net panels form a V-shape. The net is attached to the frame via ties. The net comprises a diamond mesh. The angle of convergence between the two converging net panels is substantially 60°. The frame comprises two front spaced legs and a rear spaced leg forms a tripod. The length of the rear spaced leg is longer than the two front spaced legs. The angle between the two front spaced legs is substantially 60°. The angle between the rear spaced leg and each of the two front spaced legs is substantially 60°. The ball is a cricket ball.
Patent NZ-627875-A (NZ)
Title: Long-acting nanoparticulate arthropod repellent formulations and methods of use thereof
Inventor: DELAVEAU JEAN
IPC: A01P17/00
Filed: 2013-01-28
Abstract: Disclosed are nanoencapsulated compositions with long-acting/slow-release properties and improved safety and efficacy profiles, for repelling insects and other arthropod pests away from animals, including humans. Also disclosed are methods of preparing the nanoparticle formulations. In a particular embodiment, the formulations comprising as an active ingredient a coumarin derivative (EV6062 or EV06062) The formulations also prevent illness and disease caused by insect/pest-borne vectors, and provide safer, more effective alternatives to existing repellents.
Patent NZ-630825-A (NZ)
Title: Power controller for supplying a load
Inventor: ROSS HADDON SPEAKMAN
IPC: H02J7/00
Filed: 2014-08-14
Abstract: Disclosed is a power controller for supplying a load (120) from first and second power supplies. The power controller comprises a first storage means (315) arranged to store power from the first power supply and switching means (325,335) arranged to switch between a second storage means (330) and the first storage means (315) or the second power supply depending on a parameter of the first (315) and second (330) storage means. The system further comprises a power supply means arranged to supply power to the load (120) from the second storage means (330).